Genetics of Parkinson's Disease and Related Disorders-Identifying Genes and Presymptomatic Markers The role of genetics in Parkinson's disease (PD) is now well established, with three genes identified as causal, and multiple additional loci associated with additional gene discovery efforts underway. We continue to ascertain familial Parkinson's disease in order to facilitate Mendelian and complex gene discovery, through clinical characterization and sample collection of affected, at risk, and unaffected subjects. This is in collaboration with the Laboratory of Neurogenetics NIA (John Hardy, PI, Andrew Singleton) and NHGRI (Robert Nussbaum, PI, Grisel Lopez). We are building a case control series of typical Parkinson's disease (banked at the NINDS Genetics Repository) under a currently existing protocol via NIA. We have a protocol pending at NINDS.
Our aim i s to get 500 PD cases and 500 controls which will allow a complete genome screen. By virtue of repository submission, these samples will be nationally available to genetics researchers (without any personal identifying information). Identifying more mutations will be valuable in determining the genotype/phenotype relationships. Those families in which no known loci contribute to disease will be used in gene discovery efforts by positional cloning in collaboration with the NIA Laboratory of Neurogenetics (Hardy, Singleton). In addition, we are focusing on collection of cases and families with parkinsonism from ethnic groups other than those with European background. This is important not only from a health disparities but also from a scientific standpoint. Families in which Parkinson's disease occurs in a Mendelian fashion offer a valuable resource for identifying the earliest manifestations of disease, by allowing those at risk to be followed longitudinally in order to identify those features. Identifying such early features of disease will in turn allow tools to be developed for generalized screening tests. The literature suggests possibly useful tools for this purpose; however, rigorous development of suggested tools remains to be done. The first step of such efforts is the general goal of this project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Intramural Research (Z01)
Project #
1Z01NS003006-03
Application #
7143924
Study Section
(FPDU)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
2005
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
McInerney-Leo, Aideen; Hadley, Donald W; Gwinn-Hardy, Katrina et al. (2005) Genetic testing in Parkinson's disease. Mov Disord 20:1-10
Wu, Ruey-Meei; Bounds, Rebecca; Lincoln, Sarah et al. (2005) Parkin mutations and early-onset parkinsonism in a Taiwanese cohort. Arch Neurol 62:82-7
Hernandez, Dena; Paisan Ruiz, Coro; Crawley, Anthony et al. (2005) The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases. Neurosci Lett 389:137-9
Simon-Sanchez, Javier; Hanson, Melissa; Singleton, Amanda et al. (2005) Analysis of SCA-2 and SCA-3 repeats in Parkinsonism: evidence of SCA-2 expansion in a family with autosomal dominant Parkinson's disease. Neurosci Lett 382:191-4
Miller, D W; Hague, S M; Clarimon, J et al. (2004) Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62:1835-8
Rogaeva, Ekaterina; Johnson, Janel; Lang, Anthony E et al. (2004) Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol 61:1898-904
Dogu, Okan; Johnson, Janel; Hernandez, Dena et al. (2004) A consanguineous Turkish family with early-onset Parkinson's disease and an exon 4 parkin deletion. Mov Disord 19:812-6
Singleton, Andrew; Gwinn-Hardy, Katrina (2004) Parkinson's disease and dementia with Lewy bodies: a difference in dose? Lancet 364:1105-7
Johnson, J; Hague, S M; Hanson, M et al. (2004) SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology 63:554-6
Singleton, A B; Farrer, M; Johnson, J et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302:841

Showing the most recent 10 out of 19 publications